Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Women's Health and Genetics/Laboratory Corporation of America, |
RCV003123521 | SCV003801175 | likely pathogenic | Marinesco-Sjögren syndrome | 2023-01-05 | criteria provided, single submitter | clinical testing | Variant summary: SIL1 c.1038delC (p.Glu347ArgfsX6) results in a premature termination codon predicted to cause a truncation of the encoded protein, a commonly known mechanism for disease. Although it is not expected to cause nonsense mediated decay, truncations downstream of this variant have been classified as pathogenic in ClinVar and have been associated with disease (HGMD database). The variant was absent in 245016 control chromosomes (gnomAD). To our knowledge, no occurrence of c.1038delC in individuals affected with Marinesco-Sjogren Syndrome and no experimental evidence demonstrating its impact on protein function have been reported. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014. Based on the evidence outlined above, the variant was classified as likely pathogenic. |